Smith & Nephew (SNN) Other Non-Current Assets (2009 - 2025)
Smith & Nephew (SNN) reported Other Non-Current Assets of $164.0 million for Q4 2025, up 583.33% on a YoY basis from $24.0 million in Q4 2024, and up 234.69% quarter-over-quarter from $49.0 million in Q2 2025.
Smith & Nephew (SNN) Other Non-Current Assets (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Other Non-Current Assets for 12 years, with the latest figure at $164.0 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 583.33% year-over-year to $164.0 million; the trailing twelve-month figure through Dec 2025 stood at $164.0 million (up 583.33% YoY), and the FY2025 full-year result was $164.0 million, up 583.33% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $164.0 million, up from $49.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $164.0 million in Q4 2025, with the low at $12.0 million in Q4 2022.
- Historically, Other Non-Current Assets has averaged $42.7 million across 5 years, with a median of $18.0 million in 2023.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets sank 54.55% — and 2025, when it jumped 583.33%.
- Smith & Nephew's Other Non-Current Assets stood at $15.0 million in 2021, then slipped by 20.0% to $12.0 million in 2022, then jumped by 50.0% to $18.0 million in 2023, then jumped by 33.33% to $24.0 million in 2024, then jumped by 583.33% to $164.0 million in 2025.
- The last three Other Non-Current Assets figures came in at $164.0 million (Q4 2025), $49.0 million (Q2 2025), and $24.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | 164.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 164.00 Mn |
| Jun 28, 2025 | 49.00 Mn |
| Dec 31, 2024 | 24.00 Mn |
| Jun 29, 2024 | 17.00 Mn |
| Dec 31, 2023 | 18.00 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Dec 31, 2020 | 33.00 Mn |
| Jun 30, 2020 | 30.00 Mn |
| Dec 31, 2019 | 35.00 Mn |
| Jun 29, 2019 | 33.00 Mn |
| Dec 31, 2018 | 16.00 Mn |
| Jun 30, 2018 | 13.00 Mn |
| Dec 31, 2017 | 16.00 Mn |
| Mar 31, 2012 | 128.00 Mn |
| Dec 31, 2011 | 125.00 Mn |
| Dec 31, 2009 | 14.00 Mn |